Journal
AMERICAN JOURNAL OF HUMAN GENETICS
Volume 83, Issue 4, Pages 495-503Publisher
CELL PRESS
DOI: 10.1016/j.ajhg.2008.09.004
Keywords
-
Categories
Funding
- Academy of Finland [109784]
- Biocenter Oulu
- Sigrid Juselius Foundation
- Academy of Finland (AKA) [109784, 109784] Funding Source: Academy of Finland (AKA)
Ask authors/readers for more resources
Lysyl hydroxylase 3 (LH3, encoded by PLOD3) is a multifunctional enzyme capable of catalyzing hydroxylation of lysyl residues and O-glycosylation of hydroxylysyl residues producing either monosaccharide (Gal) or disaccharide (Glc-Gal) derivatives, reactions that form part of the many posttranslational modifications required during collagen biosynthesis. Animal studies have confirmed the importance of LH3, particularly in biosynthesis of the highly glycosylated type IV and VI collagens, but to date, the functional significance in vivo of this enzyme in man is predominantly unknown. We report here a human disorder of LH3 presenting as a compound heterozygote with recessive inheritance. One mutation dramatically reduced the sugar-transfer activity of LH3, whereas another abrogated lysyl hydroxylase activity; these changes were accompanied by reduced LH3 protein levels in cells. The disorder has a unique phenotype causing severe morbidity as a result of features that overlap with a number of known collagen disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available